Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing

被引:0
|
作者
C. Moses
S. I. Hodgetts
F. Nugent
G. Ben-Ary
K. K. Park
P. Blancafort
A. R. Harvey
机构
[1] The University of Western Australia,School of Human Sciences, Faculty of Science
[2] The Harry Perkins Institute of Medical Research,Cancer Epigenetics Laboratory
[3] Perron Institute for Neurological and Translational Science,School of Molecular Sciences, Faculty of Science
[4] The University of Western Australia,Department of Neurological Surgery, Miami Project to Cure Paralysis
[5] University of Miami Miller School of Medicine,Greehey Children’s Cancer Research Institute
[6] UT Health San Antonio,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
After damage to the adult mammalian central nervous system (CNS), surviving neurons have limited capacity to regenerate and restore functional connectivity. Conditional genetic deletion of PTEN results in robust CNS axon regrowth, while PTEN repression with short hairpin RNA (shRNA) improves regeneration but to a lesser extent, likely due to suboptimal PTEN mRNA knockdown using this approach. Here we employed the CRISPR/dCas9 system to repress PTEN transcription in neural cells. We targeted the PTEN proximal promoter and 5′ untranslated region with dCas9 fused to the repressor protein Krüppel-associated box (KRAB). dCas9-KRAB delivered in a lentiviral vector with one CRISPR guide RNA (gRNA) achieved potent and specific PTEN repression in human cell line models and neural cells derived from human iPSCs, and induced histone (H)3 methylation and deacetylation at the PTEN promoter. The dCas9-KRAB system outperformed a combination of four shRNAs targeting the PTEN transcript, a construct previously used in CNS injury models. The CRISPR system also worked more effectively than shRNAs for Pten repression in rat neural crest-derived PC-12 cells, and enhanced neurite outgrowth after nerve growth factor stimulation. PTEN silencing with CRISPR/dCas9 epigenetic editing may provide a new option for promoting axon regeneration and functional recovery after CNS trauma.
引用
收藏
相关论文
共 50 条
  • [1] Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing
    Moses, C.
    Hodgetts, S., I
    Nugent, F.
    Ben-Ary, G.
    Park, K. K.
    Blancafort, P.
    Harvey, A. R.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum
    Xiao, Bo
    Yin, Shigang
    Hu, Yang
    Sun, Maoxin
    Wei, Jieqiong
    Huang, Zhenghui
    Wen, Yuhao
    Dai, Xueyu
    Chen, Huiling
    Mu, Jianbing
    Cui, Liwang
    Jiang, Lubin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (01) : 255 - 260
  • [3] CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
    Cai, Ruijie
    Lv, Runyu
    Shi, Xin'e
    Yang, Gongshe
    Jin, Jianjun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [4] Transcriptional regulation by CRISPR/dCas9 in common wheat
    Zhou, Huajie
    Xu, Lei
    Li, Feng
    Li, Yansha
    GENE, 2022, 807
  • [5] dCas9 techniques for transcriptional repression in mammalian cells: Progress, applications and challenges
    Li, Yuanyuan
    Zhou, Li-quan
    BIOESSAYS, 2021, 43 (09)
  • [6] Epigenetic control of heparanase expression through CRISPR/dCas9
    Zeng, Guihua
    Liang, Fu-Sen
    Cui, Lina
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
    Moses, Colette
    Nugent, Fiona
    Waryah, Charlene Babra
    Garcia-Bloj, Benjamin
    Harvey, Alan R.
    Blancafort, Pilar
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 14 : 287 - 300
  • [8] Crispr/dCas9 and gene activation
    Akinci, Ersin
    Unal, Pelin
    Badakul, Gamze
    Yildiz, Mehmet
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S42 - S42
  • [9] Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors
    Wang, Hong
    Guo, Rui
    Du, Zhonghua
    Bai, Ling
    Li, Lingyu
    Cui, Jiuwei
    Li, Wei
    Hoffman, Andrew R.
    Hu, Ji-Fan
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 11 : 23 - 33
  • [10] CRISPR/dCas9 platforms in plants: strategies and applications beyond genome editing
    Moradpour, Mahdi
    Abdulah, Siti Nor Akmar
    PLANT BIOTECHNOLOGY JOURNAL, 2020, 18 (01) : 32 - 44